1. Home
  2. GPK vs BEAM Comparison

GPK vs BEAM Comparison

Compare GPK & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Graphic Packaging Holding Company

GPK

Graphic Packaging Holding Company

HOLD

Current Price

$9.57

Market Cap

2.9B

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$29.37

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPK
BEAM
Founded
2007
2017
Country
United States
United States
Employees
23000
N/A
Industry
Containers/Packaging
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.0B
IPO Year
2007
2019

Fundamental Metrics

Financial Performance
Metric
GPK
BEAM
Price
$9.57
$29.37
Analyst Decision
Hold
Buy
Analyst Count
9
12
Target Price
$13.08
$50.75
AVG Volume (30 Days)
5.5M
2.1M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
4.53%
N/A
EPS Growth
N/A
82.31
EPS
1.48
N/A
Revenue
$8,617,000,000.00
$24,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.15
$33.77
P/E Ratio
$6.56
N/A
Revenue Growth
N/A
33.33
52 Week Low
$8.79
$15.52
52 Week High
$23.76
$36.44

Technical Indicators

Market Signals
Indicator
GPK
BEAM
Relative Strength Index (RSI) 45.41 53.99
Support Level $9.17 $25.36
Resistance Level $10.02 $32.01
Average True Range (ATR) 0.35 1.94
MACD 0.06 -0.02
Stochastic Oscillator 45.98 53.51

Price Performance

Historical Comparison
GPK
BEAM

About GPK Graphic Packaging Holding Company

Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Americas Paperboard Packaging, and International Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company operates in Americas, Europe and Asia Pacific regions.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: